Streetbeat News

Stock Prices

TSLA

Elon Musk hinted at a potential $20,000 Tesla Model Y during Tesla's 2024 Annual Stockholder Meeting, sparking mixed reactions from industry experts. While some see it as a game-changer, others believe it would require significant compromises. The announcement comes amid high interest rates and competition from more affordable models in China.

Portfolio Pulse from Benzinga Neuro

June 17, 2024 | 12:04 pm

SLDP

Solid Power has appointed Linda Heller as its new CFO and Treasurer, effective immediately. This leadership change is expected to bring new strategic direction to the company.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:04 pm

AVGO

CSCO

MRVL

NVDA

Broadcom Inc. (NASDAQ: AVGO) is making significant strides in the datacenter and AI Ethernet switching market, holding an 80% market share. JPMorgan analyst Harlan Sur highlights Broadcom's innovation with its Tomahawk series, which is ahead of competitors like Nvidia, Marvell, and Cisco. Broadcom's AI networking silicon revenues are expected to triple in 2024, driven by the upcoming Tomahawk 6 chipset. The company is also working on the 2nm Tomahawk 7, ensuring it stays ahead in the market.

Portfolio Pulse from Surbhi Jain

June 17, 2024 | 12:04 pm

SLRX

Salarius Pharmaceuticals announced that MD Anderson Cancer Center presented clinical data on seclidemstat for MDS and CMML at the 2024 European Hematology Association Congress. The Phase 1/2 study showed a 43% overall response rate among 14 patients, with a median overall survival of 18.5 months and median event-free survival of 7.2 months.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:03 pm

DLTR

EL

KLG

TSN

The article highlights four oversold stocks in the consumer staples sector that may present buying opportunities in Q2. These stocks include Tyson Foods Inc (TSN), Estee Lauder Companies Inc (EL), WK Kellogg Co (KLG), and Dollar Tree Inc (DLTR). Each company has experienced significant stock price declines and has an RSI value near or below 30, indicating potential undervaluation.

Portfolio Pulse from Avi Kapoor

June 17, 2024 | 12:03 pm

ELUT

Elutia has announced a $13.26 million registered direct offering, which includes 3.175 million shares of Class A stock priced at $3.40 per share and 725,000 prefunded warrants to purchase shares at $3.399 per share.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:03 pm

SCPX

Scorpius Holdings has received a notice from NYSE American regarding the intent to delist its common stock due to a low selling price. The company plans to appeal this determination to the Listing Qualifications Panel.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:02 pm

ALKS

Over the past three months, 7 analysts have shared their evaluations of Alkermes (NASDAQ:ALKS), revealing a range of outlooks from bullish to bearish. The average 12-month price target is $39.43, with a high of $50.00 and a low of $34.00. Recent analyst actions include upgrades and maintained ratings, reflecting evolving market conditions and company performance.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:01 pm

HLIT

Over the past three months, five analysts have evaluated Harmonic (NASDAQ:HLIT), all maintaining a bullish stance. The average 12-month price target remains at $18.00. Despite a 22.57% decline in revenue growth, Harmonic shows strong net margins and efficient asset use, though it struggles with ROE.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:01 pm

KYMR

Analysts have provided mixed ratings for Kymera Therapeutics (NASDAQ:KYMR) over the past three months, with a majority being bullish. The average 12-month price target has increased slightly to $48.6. Financial metrics show positive revenue growth but challenges in ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

June 17, 2024 | 12:01 pm